First Look: Decillion Healthcare Acquired

MHW learned today that BioMatrix Specialty Pharmacy announced that it has acquired Decillion Healthcare, near Columbus, Ohio.

Decillion provides individualized pharmacy and clinical support services for patients with chronic, difficult to treat conditions in neurology, oncology, gastroenterology, immunology, rheumatology and more.

Decillion also provides infusion services from their wholly-owned ambulatory infusion center in Dublin, Ohio. The pharmacy is accredited by the Joint Commission and is a member organization of the NHIA Standards for Ethical Practice.

Resulting from the acquisition, BioMatrix enhances its capabilities in neurology, oncology and limited distribution drugs, while also establishing a bricks and mortar location in Ohio. The acquisition expands the BioMatrix footprint to twelve (12) specialty pharmacy locations nationwide, serving over 1,700 patients across a range of therapeutic categories.

“Decillion’s commitment to individualized patient care makes them a great addition to the BioMatrix family of companies,” said Bruce Greenberg, CEO at BioMatrix. “We are excited to expand our services further in the neurology, oncology and limited distribution drug categories, bringing our proven model of care to patients who need it the most.”

This post was written by:

- who has written 371 posts on mHealthWatch.

Contact the author